Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.

This report provides a complete quantitative data and qualitative analysis on the global market for Polypeptide Drug. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Polypeptide Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Polypeptide Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Polypeptide Drug, including the following market information:
Global Polypeptide Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Polypeptide Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Polypeptide Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Polypeptide Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players
Major competitors identified in this market include Novartis, Merck Serono, Ferring Pharmaceuticals, Ipsen PHarma Biotech, Lilly, Asahi Kasei, AstraZeneca, SciClone Pharmaceuticals, Takeda, Roche, Sanofi, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration

Based on the Application:
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)